Mechanisms of cellular therapy in respiratory diseases

[1]  K. Tan,et al.  Cardiomyocytes from Human Embryonic Stem Cells , 2013 .

[2]  Y. Moodley,et al.  Cellular therapies for lung disease: A distant horizon , 2011, Respirology.

[3]  Xing-hua Chen,et al.  Granulocyte-colony stimulating factor-mobilized mesenchymal stem cells: A new resource for rapid engraftment in hematopoietic stem cell transplantation. , 2011, Medical hypotheses.

[4]  P. Rocco,et al.  Effects of bone marrow-derived mononuclear cells on airway and lung parenchyma remodeling in a murine model of chronic allergic inflammation , 2011, Respiratory Physiology & Neurobiology.

[5]  H. Broxmeyer,et al.  Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. , 2011, American journal of respiratory and critical care medicine.

[6]  O. Greco,et al.  Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema , 2011, International journal of chronic obstructive pulmonary disease.

[7]  A. Liras.  Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects , 2010, Journal of Translational Medicine.

[8]  M. Matthay,et al.  Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL‐37 , 2010, Stem cells.

[9]  Arthur S Slutsky,et al.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.

[10]  B. Thompson,et al.  Therapeutic potential of mesenchymal stem cells for severe acute lung injury. , 2010, Chest.

[11]  C. Takiya,et al.  Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis , 2010, European Respiratory Journal.

[12]  C. Takiya,et al.  Bone Marrow Mononuclear Cell Therapy Led to Alveolar-Capillary Membrane Repair, Improving Lung Mechanics in Endotoxin-Induced Acute Lung Injury , 2010, Cell transplantation.

[13]  Jian-cheng Xu,et al.  INTRAVENOUS DELIVERY OF BONE MARROW-DERIVED ENDOTHELIAL PROGENITOR CELLS IMPROVES SURVIVAL AND ATTENUATES LIPOPOLYSACCHARIDE-INDUCED LUNG INJURY IN RATS , 2010, Shock.

[14]  P. Pelosi,et al.  Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury , 2010, Critical care medicine.

[15]  Jae W. Lee,et al.  Allogeneic Human Mesenchymal Stem Cells Restore Epithelial Protein Permeability in Cultured Human Alveolar Type II Cells by Secretion of Angiopoietin-1*♦ , 2010, The Journal of Biological Chemistry.

[16]  J. Lei,et al.  Autocrine production of TGF-beta1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[17]  B. Gutfilen,et al.  Intrabronchial instillation of bone marrow derived mononuclear cells in silicotic patients: Nuclear medicine analysis and follow-up , 2010, ATS 2010.

[18]  M. Mathru.  Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung , 2010 .

[19]  A. Malkinson,et al.  Clara cell: progenitor for the bronchiolar epithelium. , 2010, The international journal of biochemistry & cell biology.

[20]  B. Gutfilen,et al.  Intratracheal instillation of bone marrow-derived cell in an experimental model of silicosis , 2009, Respiratory Physiology & Neurobiology.

[21]  B. Stripp,et al.  Bronchiolar progenitor cells. , 2009, Proceedings of the American Thoracic Society.

[22]  G. Stamp,et al.  Bone Marrow Stem Cells Expressing Keratinocyte Growth Factor via an Inducible Lentivirus Protects against Bleomycin-Induced Pulmonary Fibrosis , 2009, PloS one.

[23]  P. Lønning,et al.  Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. , 2009, Cancer research.

[24]  S. Savitz,et al.  Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. , 2009, Stem cells and development.

[25]  G. Martin,et al.  Recent trends in acute lung injury mortality: 1996–2005* , 2009, Critical care medicine.

[26]  Leelee Ong,et al.  Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. , 2009, Microvascular research.

[27]  M. Burdick,et al.  The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. , 2009, Transactions of the American Clinical and Climatological Association.

[28]  S. Janes,et al.  Mesenchymal stem cells as vectors for lung disease. , 2008, Proceedings of the American Thoracic Society.

[29]  D. Krause.  Bone marrow-derived cells and stem cells in lung repair. , 2008, Proceedings of the American Thoracic Society.

[30]  M. Matthay.  Treatment of acute lung injury: clinical and experimental studies. , 2008, Proceedings of the American Thoracic Society.

[31]  P. Pelosi,et al.  Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality? , 2008, Current opinion in critical care.

[32]  N. Horwood,et al.  Potential of mesenchymal stem cell therapy , 2007, Current opinion in oncology.

[33]  Giselle Chamberlain,et al.  Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.

[34]  D. Stewart,et al.  Competing Interests: This work was , 2022 .

[35]  Jae W. Lee,et al.  Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1 , 2007, The Journal of Immunology.

[36]  L. Ortiz,et al.  Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury , 2007, Proceedings of the National Academy of Sciences.

[37]  S. Kitamura,et al.  Effect of Hypoxia on Gene Expression of Bone Marrow‐Derived Mesenchymal Stem Cells and Mononuclear Cells , 2007, Stem cells.

[38]  F. Martinez,et al.  Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. , 2007, The Journal of clinical investigation.

[39]  A. Burns,et al.  A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[40]  T. Nagayasu,et al.  FIBROBLAST GROWTH FACTOR-2 PROMOTES RECOVERY OF PULMONARY FUNCTION IN A CANINE MODELS OF ELASTASE-INDUCED EMPHYSEMA , 2007, Experimental lung research.

[41]  John S. Van Arnam,et al.  Threshold of Lung Injury Required for the Appearance of Marrow‐Derived Lung Epithelia , 2006, Stem cells.

[42]  A. Avogaro,et al.  Circulating Progenitor Cells Are Reduced in Patients with Severe Lung Disease , 2006, Stem cells.

[43]  M. Moss,et al.  Progenitor cells in acute lung injury. , 2006, Minerva anestesiologica.

[44]  B. Willis,et al.  Epithelial origin of myofibroblasts during fibrosis in the lung. , 2006, Proceedings of the American Thoracic Society.

[45]  J. Polak,et al.  Derivation of Distal Lung Epithelial Progenitors from Murine Embryonic Stem Cells Using a Novel Three‐Step Differentiation Protocol , 2006, Stem cells.

[46]  D. Stewart,et al.  Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene Transfer Materials and Methods Cell Isolation and Culture , 2022 .

[47]  P. Palange,et al.  Circulating haemopoietic and endothelial progenitor cells are decreased in COPD , 2006, European Respiratory Journal.

[48]  V. Peinado,et al.  Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory cell and molecular biology.

[49]  P. N. Rao,et al.  Circulating Progenitor Epithelial Cells Traffic via CXCR4/CXCL12 in Response to Airway Injury1 , 2006, The Journal of Immunology.

[50]  A. Trumpp,et al.  Bone-marrow haematopoietic-stem-cell niches , 2006, Nature Reviews Immunology.

[51]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[52]  A. Quyyumi,et al.  Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. , 2005, American journal of respiratory and critical care medicine.

[53]  T. Jacks,et al.  Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.

[54]  R. Mulligan,et al.  Failure of bone marrow to reconstitute lung epithelium. , 2005, American journal of respiratory cell and molecular biology.

[55]  M. Rojas,et al.  Bone marrow-derived mesenchymal stem cells in repair of the injured lung. , 2005, American journal of respiratory cell and molecular biology.

[56]  S. Rennard,et al.  Cells derived from the circulation contribute to the repair of lung injury. , 2004, American journal of respiratory and critical care medicine.

[57]  H. Kubo,et al.  Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. , 2004, Biochemical and biophysical research communications.

[58]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[59]  ToyoakiMurohara,et al.  Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers , 2004 .

[60]  S Chunmeng,et al.  Effects of plastic-adherent dermal multipotent cells on peripheral blood leukocytes and CFU-GM in rats. , 2004, Transplantation proceedings.

[61]  J. Itskovitz‐Eldor,et al.  Differentiation of Human Embryonic Stem Cells into Insulin‐Producing Clusters , 2004, Stem cells.

[62]  M. Burnett,et al.  Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.

[63]  S. Phan,et al.  Bone marrow-derived progenitor cells in pulmonary fibrosis. , 2004, The Journal of clinical investigation.

[64]  N. Anthonisen,et al.  Contemporary management of chronic obstructive pulmonary disease: scientific review. , 2003, JAMA.

[65]  Naftali Kaminski,et al.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. Goss,et al.  Incidence of acute lung injury in the United States. , 2003, Critical care medicine.

[67]  S. Yamanaka,et al.  Role of ERas in promoting tumour-like properties in mouse embryonic stem cells , 2003, Nature.

[68]  J. Greenberger,et al.  Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.

[69]  D. Prockop,et al.  Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  S. Badve,et al.  Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. , 2002, Experimental hematology.

[71]  D. Kotton,et al.  Bone marrow-derived cells as progenitors of lung alveolar epithelium. , 2001, Development.

[72]  S. Randell,et al.  Evidence for stem-cell niches in the tracheal epithelium. , 2001, American journal of respiratory cell and molecular biology.

[73]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[74]  Jill Moss,et al.  Mesenchymal precursor cells in the blood of normal individuals , 2000, Arthritis Research & Therapy.